| CTRI Number |
CTRI/2020/08/027380 [Registered on: 26/08/2020] Trial Registered Prospectively |
| Last Modified On: |
08/01/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Safety in Use Study] |
| Study Design |
Other |
|
Public Title of Study
|
Baby Soap study in healthy babies |
|
Scientific Title of Study
|
Safety In-Use Study to Assess the Cutaneous Tolerance of Baby Soap in Healthy Babies of 0 to 36 Months of Age |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| C3B00297 Version: 01, Dated 06 Aug 20 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Nayan Patel |
| Designation |
Principal Investigator |
| Affiliation |
Cliantha Research |
| Address |
Consumer Research Department
Garden View Corporate House No 7
Opp Auda Garden
Bodakdev Ahmedabad 380054 India
Ahmadabad GUJARAT 380054 India |
| Phone |
9909013286 |
| Fax |
07966219549 |
| Email |
nkpatel@cliantha.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Nayan Patel |
| Designation |
Principal Investigator |
| Affiliation |
Cliantha Research |
| Address |
Consumer Research Department
Garden View Corporate House No 7
Opp Auda Garden
Bodakdev Ahmedabad 380054 India
Ahmadabad GUJARAT 380054 India |
| Phone |
9909013286 |
| Fax |
07966219549 |
| Email |
nkpatel@cliantha.com |
|
Details of Contact Person Public Query
|
| Name |
Ms Maheshvari Patel |
| Designation |
Associate Director-Consumer Research |
| Affiliation |
Cliantha Research |
| Address |
Consumer Research Department
Garden View Corporate House No 7
Opp Auda Garden
Bodakdev Ahmedabad 380054 India
Ahmadabad GUJARAT 380054 India |
| Phone |
9909013236 |
| Fax |
07966219549 |
| Email |
mnpatel@cliantha.com |
|
|
Source of Monetary or Material Support
|
| OM Children’s Hospital,
304-305, Silver Star Commercial Complex,
Silver Star Crossroads, New Chandlodia,
Ahmedabad – 382481 |
|
|
Primary Sponsor
|
| Name |
Azafran Innovacion Limited |
| Address |
Dishman Corporate House,
Jayantilal Park BRTS Bus Stop,
Iscon-Bopal Road, Ambli,
Ahmedabad, Gujarat 380009 |
| Type of Sponsor |
Other [Cosmetics Industries] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Not Applicable |
Not Applicable |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Nayan Patel |
Cliantha Research |
Consumer Research Department,
Garden View Corporate House No. 7
Opp. Auda Garden
Bodakdev
Ahmedabad 380054
India Ahmadabad GUJARAT |
9909013286 07966219549 nkpatel@cliantha.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| ACEAS IEC |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Babies in the age group of 0 (including new born full term babies Day 1) to 36 months (both inclusive at the time of consent). |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Baby soap |
Wet baby’s face and body; apply the Baby Soap generously, gently working up a lather and rinse well.
Use once daily for 14 days.
|
| Comparator Agent |
Not Applicable |
Not Applicable |
|
|
Inclusion Criteria
|
| Age From |
1.00 Day(s) |
| Age To |
36.00 Month(s) |
| Gender |
Both |
| Details |
1) Babies in the age group of 0 (including new born full term babies of Day 1) to 36 months (inclusive of both genders) at the time of consent.
2) APGAR score >7 at 1 and 5 minutes with no resuscitation required at birth for babies of 0-7 days.
3) Babies general in good health as determined from a recent medical history
4) Babies mother/legal representative, preferably mother willing to give a voluntary written parental informed consent and agree to come for regular follow up.
5) Babies mother/legal representative, preferably mother willing to abide by and comply with the study protocol.
6) Babies should not participate in any other clinical study during participation in the current study. |
|
| ExclusionCriteria |
| Details |
1) Babies’ mother/ legal caretaker not willing to stop the use of other baby body milk /lotion / massage oil or any other baby face/body moisturizing product during the study period.
2) Chronic illness which may influence the cutaneous state as per Investigator.
3) Babies on any systemic medication.
4) Babies participating in a similar clinical study, currently or during the previous 30 days.
5) Any baby, in the Investigators opinion not considered suitable for enrollment.
6) A known history or present condition of allergic response to any other concern that may require medical attention.
7) Babies with medical history (past | present) of significant dermatological diseases or conditions, such as atopy, psoriasis, vitiligo or other conditions known to alter skin appearance or physiologic response (e.g. porphyria) chronic urticaria, or sunburn, rashes. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. The safety of the test product will be evaluated the on skin in terms of mildness, gentleness and non-irritability of babies’ skin by pediatrician assessment change from baseline.
2. To determine the baby experienced no tear, provide quick clean, smooth and gentle effect on baby skin and hair by subjective assessment questionnaire from babies’ mother/ legal caretaker after test product application on Day 15. |
1. Day 01 before application to Day 15 after application.
2. Day 15 after test product application. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| 1. The effect of test product will be evaluated on improvement in the skin hydration using Corneometer® CM 825 or MoistureMeter SC change from baseline. |
1. Day 01 before application to Day 15 after application. |
|
|
Target Sample Size
|
Total Sample Size="36" Sample Size from India="36"
Final Enrollment numbers achieved (Total)= "38"
Final Enrollment numbers achieved (India)="38" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
31/08/2020 |
| Date of Study Completion (India) |
30/10/2020 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="0" Days="15" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
Not Applicable |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is proposed to evaluate and establish the benefits of the
test product on mildness, gentleness and non-irritability on baby’s skin and
soothes the baby’s skin and hair, also determines the experience of no tears
and keeps the baby’s skin moisturized and hydrated after bath, upon application
relieving dryness, redness, oedema, urticarThis study is proposed to evaluate and establish the benefits of the
test product on mildness, gentleness and non-irritability on baby’s skin and
soothes the baby’s skin and hair, also determines the experience of no tears
and keeps the baby’s skin moisturized and hydrated after bath, upon application
relieving dryness, redness, oedema, urticarial and any other reactions. The
proposed benefits are evaluated by the paediatrics, subjective assessment
questionnaire and instrumental evaluation by the dermatologist/dermatologist
trained evaluator and assessment questionnaire at Day 1 and Day15.ial and any other reactions. The
proposed benefits are evaluated by the paediatrics, subjective assessment
questionnaire and instrumental evaluation by the dermatologist/dermatologist
trained evaluator and assessment questionnaire at Day 1 and Day15. |